Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevent...

por Mikol, Daniel D., Snellman, Josefin
Publicado 2019

Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials

por Lampl, Christian, Kraus, Viktoria, Lehner, Katrina, Loop, Brett, Chehrenama, Mahan, Maczynska, Zofia, Ritter, Shannon, Klatt, Jan, Snellman, Josefin
Publicado 2022

Acute destruction of the synaptic ribbon reveals a role for the ribbon in vesicle priming

por Snellman, Josefin, Mehta, Bhupesh, Babai, Norbert, Bartoletti, Theodore M., Akmentin, Wendy, Francis, Adam, Matthews, Gary, Thoreson, Wallace, Zenisek, David
Publicado 2011

Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study

por Pozo-Rosich, Patricia, Lucas, Christian, Watson, David P. B., Gaul, Charly, Ramsden, Emma, Ritter, Shannon, Martelletti, Paolo, Snellman, Josefin
Publicado 2021

Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans

por Do, Thien Phu, Deligianni, Christina, Amirguliyev, Sarkhan, Snellman, Josefin, Lopez, Cristina Lopez, Al-Karagholi, Mohammad Al-Mahdi, Guo, Song, Ashina, Messoud
Publicado 2023

Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study

por Pellesi, Lanfranco, Al-Karagholi, Mohammad Al-Mahdi, De Icco, Roberto, Chaudhry, Basit Ali, Lopez, Cristina Lopez, Snellman, Josefin, Hannibal, Jens, Amin, Faisal Mohammad, Ashina, Messoud
Publicado 2022

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial

por Pellesi, Lanfranco, Al-Karagholi, Mohammad Al-Mahdi, De Icco, Roberto, Coskun, Hande, Elbahi, Fatima Azzahra, Lopez-Lopez, Cristina, Snellman, Josefin, Hannibal, Jens, Amin, Faisal Mohammad, Ashina, Messoud
Publicado 2021

Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study

por Cullum, Christopher Kjaer, Do, Thien Phu, Ashina, Messoud, Bendtsen, Lars, Hugger, Sarah Sonja, Iljazi, Afrim, Gusatovic, Julia, Snellman, Josefin, Lopez-Lopez, Cristina, Ashina, Håkan, Amin, Faisal Mohammad
Publicado 2022

Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study

por Agosti, Reto, Parzini, Catherine, Findling, Oliver, Myers, Peter, Petersen, Jens A., Ryvlin, Philippe, Sandor, Peter, Stallmach, Matthias, Zecca, Chiara, Snellman, Josefin, Ritter, Shannon, Arzt, Michael E., Rohrer, Simon, Gantenbein, Andreas R.
Publicado 2023